(Abstracted from J Minim Invasive Gynecol 2017; http://dx.doi.org/doi:10.1016/j.jmig.2017.07.022)
The aim of this article was to review current data from the literature on conservative management of endometrial cancer (EC). The authors provide the latest updates on ongoing prospective trials exploring strategies in women with medical comorbidities or those of reproductive age who want to preserve futility.
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX (C.C., S.N.W., P.T.R.); and Universidad de Buenos Aires (UBA), Buenos Aires, Argentina (N.B.S.)